SecurityTXRH / Texas Roadhouse, Inc. (882681109)
IndustryRestaurants, Dining, and Eating Places
Common Shares Outstanding71,475,375 shares (as of 2018-06-26)
Total Insiders10
Total Directors6
Total Officers5

Stock Insider Trading (from SEC Form 4)

Texas Roadhouse, Inc. insider trades are listed in the following table, followed by a table containing the full transaction history. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.

TXRH / Texas Roadhouse, Inc. insiders include Catlett Celia, MOORE GREGORY N, PARKER JAMES F, ZARLEY JAMES R, and Colosi Scott Matthew, Robinson Tonya Ramsey James, Jacobsen S. Chris, WIDMER KATHY, Taylor Wayne Kent, .

Insider Roster

Insider Dir Off 10% Shares Owned
Robinson Tonya CFO
X 1,025
Colosi Scott Matthew President and CFO
X 58,202
WIDMER KATHY Director
X
ZARLEY JAMES R Director
X
PARKER JAMES F Director
X
MOORE GREGORY N Director
X
Taylor Wayne Kent Chairman, CEO, Director
X X 3,779,473
Jacobsen S. Chris Chief Marketing Officer
X 16,533
Catlett Celia General Counsel
X 12,429
Ramsey James Director
X

Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b-5 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Form Insider Code 10b-5 Direct Share
Price
Shares
Changed
Remaining
Shares
Post Value
2018-08-06 4 Robinson Tonya F D 63.30 -477 1,025
2018-08-06 4 Robinson Tonya M D 1,500 1,502
2018-05-08 4 Colosi Scott Matthew G D -5,000 58,202
2018-03-26 4 WIDMER KATHY S D 56.51 -8,000 10,950 618,784
2018-02-23 4 ZARLEY JAMES R Zarley Investments, LP S I 56.91 -2,400 23,800 1,354,458
2018-02-23 4 ZARLEY JAMES R Zarley Family Foundation S I 56.80 -8,500 23,800 1,351,840
2018-02-16 4 Colosi Scott Matthew S D 58.55 -10,644 63,202 3,700,477
2018-02-15 4 Colosi Scott Matthew F D 57.16 -19,298 73,846
2018-02-15 4 Colosi Scott Matthew A D 40,585 93,144
2018-02-15 4 Taylor Wayne Kent F D 57.16 -53,441 3,779,473
2018-02-15 4 Taylor Wayne Kent A D 114,991 3,832,914
2018-01-26 4 MOORE GREGORY N Moore Family Trust G I 8,500 87,650
2018-01-26 4 MOORE GREGORY N G D -8,500 0
2018-01-29 4 Jacobsen S. Chris S D 60.00 -366 16,533 991,980
2018-01-26 4 Jacobsen S. Chris S D 60.00 -1,134 16,899 1,013,940
2018-01-12 4 Jacobsen S. Chris S D 57.96 -1,000 18,033 1,045,193
2018-01-11 4 Colosi Scott Matthew G D -4,412 52,559
2018-01-08 4 Catlett Celia S D 56.11 -6,337 12,429 697,391
2018-01-08 4 Catlett Celia F D 57.16 -7,571 18,766
2018-01-08 4 Catlett Celia M D 20,000 26,337
2018-01-08 4 Taylor Wayne Kent F D 57.16 -5,308 3,717,923
2018-01-08 4 Taylor Wayne Kent M D 15,000 3,723,231
2018-01-09 4 Jacobsen S. Chris S D 56.50 -2,500 19,033 1,075,364
2018-01-08 4 Jacobsen S. Chris F D 57.16 -3,651 21,533
2018-01-08 4 Jacobsen S. Chris M D 10,000 25,184
2018-01-09 4 Colosi Scott Matthew S D 56.43 -22,403 56,971 3,214,874
2018-01-08 4 Colosi Scott Matthew F D 57.16 -17,597 79,374
2018-01-08 4 Colosi Scott Matthew M D 40,000 96,971
2018-01-08 4 MOORE GREGORY N M D 8,500 87,650
2018-01-08 4 PARKER JAMES F M D 8,500 92,060
2018-01-08 4 ZARLEY JAMES R M D 8,500 147,200
2018-01-08 4 WIDMER KATHY M D 8,500 18,950
2017-12-15 4 ZARLEY JAMES R Zarley Family Foundation G I 5,000 34,700
2017-12-15 4 ZARLEY JAMES R G D -5,000 130,200
2017-12-15 4 Taylor Wayne Kent G D -100,000 3,708,231
2017-12-12 4 WIDMER KATHY S D 50.86 -1,300 10,450 531,487
2017-12-08 4 Taylor Wayne Kent S D 50.61 -100,000 3,808,231 192,734,571
2017-12-07 4 Taylor Wayne Kent S D 51.09 -200,000 3,908,231 199,671,522
2017-11-13 4 Catlett Celia S D 49.34 -3,663 6,337 312,668
2017-11-03 4 Colosi Scott Matthew G D -3,087 56,971
2017-09-21 4 WIDMER KATHY S D 47.95 -2,000 11,750 563,412
2017-08-11 4 Jacobsen S. Chris S D 49.25 -2,500 15,184 747,812
2017-05-31 4 WIDMER KATHY S D 48.97 -5,200 13,750 673,338
2017-05-09 4 Catlett Celia S D 49.95 -1,837 10,000 499,500
2017-05-09 4 Colosi Scott Matthew S D 49.54 -10,000 60,058 2,975,273
2017-05-02 4 Catlett Celia S D 50.80 -5,000 11,837 601,320
2017-05-03 4 Jacobsen S. Chris S D 51.29 -3,500 17,684 907,012
2017-03-27 4 WIDMER KATHY S D 43.17 -4,800 18,950 818,072
2017-03-02 4 MOORE GREGORY N Moore Family Trust G I 8,500 79,150
2017-03-02 4 MOORE GREGORY N G D -8,500 0
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...

Related News Stories

The Cheesecake Factory Might Be Worth A Bite

12h seekingalpha
Costs increased significantly in the quarter, but if you adjust for unusual/non-recurring expenses, CAKE isn't doing any worse than peers. (1-0)

Strong U.S. Consumer Spending Seen Boosting Q2 Retail Results

2018-08-14 seekingalpha
In the U.S. retail landscape, the strength seen in consumer spending continued into the second quarter of 2018. In fact, analysts polled by Thomson Reuters are becoming more bullish on consumer spending, as retailers get ready to report their earnings for Q2 2018. (91-1)

Del Frisco’s Restaurant Stock Is an Extremely Risky Bet at Best

2018-08-06 investorplace
It’s been a tough year for American steakhouse chain Del Frisco’s Restaurant (NASDAQ:DFRG). Del Frisco’s Restaurant stock has lost half of its value since making its way toward $20 per share in March which has led many to consider picking the beaten down stock up in hopes of a rebound. (1-0)

Stocks To Watch: Meet The New Ford

2018-08-04 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. (398-3)

Smaller Restaurants Are Starving for Sales After Earnings Misses - Bloomberg

2018-08-03 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (6-0)